Zhonghuang Li

596 citations
32 papers · 508 indexed · h-index 15
Topics
Cancer therapeutics and mechanisms (10 papers)Computational Drug Discovery Methods (6 papers)Quinazolinone synthesis and applications (6 papers)
Partner nations
ChinaUnited States

In The Last Decade

Zhonghuang Li

31 papers receiving 499 citations

Peers

Zhonghuang Li
Comparison fields: 5 of 81
  • Molecular Biology 288
  • Organic Chemistry 154
  • Oncology 101
  • Pulmonary and Respiratory Medicine 67
  • Computational Theory and Mathematics 55
Replace Qianbin Li with:
Qianbin Li China
Zhouling Xie China
Ritu Ojha India
Hanan S. Anbar Egypt
Jiann‐Jyh Huang Taiwan
Qingwei Zhang China
Shilong Ying China
Mei Su China
Samriddhi Shukla India
Kaori Morimoto Japan
Zhonghuang Li relative to Qianbin Li China Qianbin Li's profile →
Citations per field
00.5×1.5×
Qianbin Li · 1×
Citations per year

Countries citing papers authored by Zhonghuang Li

Since Specialization
Citations

This map shows the geographic impact of Zhonghuang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonghuang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonghuang Li more than expected).

Fields of papers citing papers by Zhonghuang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonghuang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonghuang Li. The network helps show where Zhonghuang Li may publish in the future.

Co-authorship network of co-authors of Zhonghuang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonghuang Li. A scholar is included among the top collaborators of Zhonghuang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonghuang Li. Zhonghuang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 1
4 6
5 5
6 16
7 22
8 16
9 11
10 15
11 2
12 26
13 1
14 13
15 15
16 42
17 21
18 32
19 32
20 47

About Zhonghuang Li

Zhonghuang Li is a scholar working on Toxicology, Pharmacology and Computational Theory and Mathematics, having authored 32 papers that have together received 508 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Computational Drug Discovery Methods (6 papers) and Quinazolinone synthesis and applications (6 papers). The work is most often cited by research in Organic Chemistry (154 citations), Pharmacology (42 citations) and Molecular Biology (288 citations). Zhonghuang Li has collaborated with scholars based in China and United States. Frequent co-authors include Jiajie Zhang, Shanhe Wan, Yuanxin Tian, Xiaoyun Wu, Guangfa Wang, Zhengguang Zhu, Hong Jin, Tingting Zhang, Ying Jiang and Shaoyu Wu. Their work appears in journals such as International Journal of Molecular Sciences, Molecules and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026